Search tips
Search criteria 


Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2010; 5(3): e9575.
Published online 2010 March 8. doi:  10.1371/journal.pone.0009575
PMCID: PMC2833197

Transcriptional Regulation of VEGF-A by the Unfolded Protein Response Pathway

Mikhail V. Blagosklonny, Editor



Angiogenesis is crucial to many physiological and pathological processes including development and cancer cell survival. Vascular endothelial growth factor-A (VEGFA) is the predominant mediator of angiogenesis in the VEGF family. During development, adverse environmental conditions like nutrient deprivation, hypoxia and increased protein secretion occur. IRE1α, PERK, and ATF6α, master regulators of the unfolded protein response (UPR), are activated under these conditions and are proposed to have a role in mediating angiogenesis.

Principal Findings

Here we show that IRE1α, PERK, and ATF6α powerfully regulate VEGFA mRNA expression under various stress conditions. In Ire1α−/− and Perk−/− mouse embryonic fibroblasts and ATF6α-knockdown HepG2 cells, induction of VEGFA mRNA by endoplasmic reticulum stress is attenuated as compared to control cells. Embryonic lethality of Ire1α−/− mice is due to the lack of VEGFA induction in labyrinthine trophoblast cells of the developing placenta. Rescue of IRE1α and PERK in Ire1α−/− and Perk−/− cells respectively, prevents VEGFA mRNA attenuation. We further report that the induction of VEGFA by IRE1α, PERK and ATF6 involves activation of transcription factors, spliced-XBP-1, ATF4 and cleaved ATF6 respectively.


Our results reveal that the IRE1α-XBP-1, PERK-ATF4, and ATF6α pathways constitute novel upstream regulatory pathways of angiogenesis by modulating VEGF transcription. Activation of these pathways helps the rapidly growing cells to obtain sufficient nutrients and growth factors for their survival under the prevailing hostile environmental conditions. These results establish an important role of the UPR in angiogenesis.


Productive folding of secretory proteins in the endoplasmic reticulum (ER) is essential to ensure normal cell function. In order for secretory proteins to fold properly, ER homeostasis must be maintained. ER homeostasis is defined by the dynamic balance between the ER protein load and the ER capacity to process this load. ER homeostasis can be perturbed by pathological processes such as hypoxia, glucose deprivation, viral infections, environmental toxins, inflammatory cytokines, and mutant protein expression, as well as by physiological processes such as aging. Disruption of ER homeostasis causes accumulation of unfolded and misfolded proteins in the ER. This condition is referred to as ER stress. Cells cope with ER stress by activating the Unfolded Protein Response (UPR) [1], [2]. The UPR is initiated by three ER transmembrane proteins: Inositol Requiring 1 (IRE1), PKR-like ER kinase (PERK), and Activating Transcription Factor 6 (ATF6). These three master regulators sense and interpret protein folding conditions in the ER and translate this information across the ER membrane to regulate downstream effectors. These effectors have two distinct outputs, homeostatic and apoptotic. Homeostatic outputs are adaptive responses that function to attenuate ER stress and restore ER homeostasis. These responses include the attenuation of protein translation to reduce ER workload and prevent further accumulation of unfolded proteins, upregulation of molecular chaperones and protein processing enzymes to enhance the ER folding activity, and the increase in ER-associated degradation (ERAD) components to promote clearance of unfolded proteins. When ER stress reaches a point where the cells cannot tolerate the load of unfolded proteins any more, apoptosis sets in [1].

Recent studies have indicated that cells suffering from insufficient blood supplies experience ER stress. The ER needs energy and oxygen for the folding process, thus nutrient deprivation (low ATP production) and hypoxia caused by insufficient blood supply leads to inefficient protein folding and ER stress in cells, especially in cancer cells that grow and spread rapidly [3], [4], [5]. This condition also occurs in the development of the placenta [6], [7], [8]. Both nutrient deprivation and hypoxia stimulate the production of vascular endothelial growth factor (VEGF) and other angiogenic factors, leading to protection against ischaemic injury [9], [10], [11]. Here we report that the three master regulators of the UPR, IRE1α, PERK and ATF6α, mediate transcriptional regulation of VEGFA under ER stress which occurs during normal development of labyrinthine trophoblast cells in the placenta as well as in cancer cells.


VEGFA Expression Is Increased by ER Stress

Vascular endothelial growth factor isoform A (VEGFA) is the most abundant variant of the VEGF family. Previous studies have shown that VEGFA is upregulated in human retinal ARPE-1 cells when treated with tunicamycin, an ER stress inducer [12]. To determine whether VEGFA expression is increased by other ER stress inducers in other cell types including cancer cells, we treated prostate cancer cell line, PC-3 (Figure 1A), liver cancer cell line, HepG2 (Figure 1B), and the insulinoma cells, INS-1 832/13 (Figure 1C), with two ER stress inducers, thapsigargin and tunicamycin for 4 hr. We found that VEGFA mRNA expression was increased 2–5 fold by ER stress. We confirmed that these cells were under ER stress by measuring expression levels of typical ER stress markers, spliced XBP-1 and BiP.

Figure 1
VEGFA mRNA expression is induced by ER stress.

HIF1α Is Not Involved in ER Stress-Mediated VEGFA Induction

HIF1α is a major regulator of VEGFA mRNA expression under hypoxia [13]. To test if HIF1α is also involved in ER stress-mediated VEGF mRNA induction, we treated HepG2 cells with either the ER stress inducer thapsigargin or hypoxia, and then measured HIF1α protein expression. HIF1α protein expression by thapsigargin treatment was much lower than that by hypoxia (Figure 2A), raising the possibility that HIF1α is not involved in ER stress-mediated VEGFA induction. To test this possibility, we knocked down HIF1α expression using siRNA directed against HIF1α in HepG2 cells, stimulated them with thapsigargin, and then measure VEGFA induction. As we predicted, siRNA-mediated knockdown of HIF1α did not affect VEGFA induction by thapsigargin (Figure 2B). These results strongly suggest that HIF1α is not a major regulator of VEGFA mRNA expression under ER stress conditions.

Figure 2
Hif1α is not required for VEGFA induction under ER stress.

IRE1α Regulates VEGFA under ER Stress Conditions via XBP-1 Splicing

IRE1α, a key regulator of the UPR, is involved in transcriptional regulation of genes upregulated by ER stress. It has been shown that IRE1α signaling is involved in VEGFA mRNA expression by glucose deprivation and hypoxia [5]. Glucose deprivation is known to activate the UPR. We were therefore interested in determining whether IRE1α was required for VEGFA mRNA expression under ER stress conditions. VEGFA mRNA expression levels were significantly decreased in Ire1α−/− mouse embryonic fibroblasts (MEFs) as compared to those in control wild-type MEFs under various ER stress conditions induced by thapsigargin (Figure 3A), tunicamycin (Figure 3B), and hypoxia (0.5% O2) (Figure 3C). ER stress during hypoxia was confirmed in wild-type MEFs by measuring upregulation of spliced Xbp-1 which was absent in Ire1α−/− cells (Figure 3C, right panel). It has been shown that IRE1α is involved in the degradation of mRNAs encoding secretory proteins [14], [15][16][17]. To determine whether IRE1α is involved in VEGFA mRNA stability under ER stress conditions, we used actinomycin D to attenuate mRNA transcription, then challenged Ire1α−/− and control cells with thapsigargin to induce VEGFA mRNA degradation. We found that IRE1α was not involved in ER stress-mediated VEGFA mRNA decay (Figure S1). To further confirm the relationship between IRE1α signaling and VEGFA mRNA induction, we established Ire1α−/− cells transduced with lentivirus expressing human IRE1α. Ire1α−/− cells rescued with human IRE1α could activate XBP-1 splicing, indicating that ectopically expressed IRE1α was functional (Figure 3D). In Ire1α−/− cells rescued human IRE1α, VEGFA mRNA expression was restored under ER stress conditions (Figure 3E). IRE1α-mediated induction of VEGFA mRNA also enhanced VEGFA protein production as well as VEGFA secretion (Figure 3F).

Figure 3
ER stress-induced VEGFA expression depends on Ire1.

IRE1α mediates XBP-1 mRNA splicing, which leads to production of an active transcription factor XBP-1-p, raising the possibility that XBP-1-p was involved in the regulation of VEGFA mRNA expression under ER stress conditions. To test this idea, we measured expression levels of VEGFA in Ire1α−/− MEFs transfected with mouse processed-XBP1 plasmid. Ectopic expression of XBP-1-p restored VEGFA induction in Ire1α−/− MEFs under ER stress conditions (Figure 3G, left panel). Although expression levels of VEGFA and spliced XBP-1 were lower in Ire1α−/− MEFs ectopically expressing XBP-1p and IRE1α as compared to control wild-type MEFs, the degree of VEGFA mRNA induction was strongly correlated with an increase in spliced Xbp1 mRNA expression (Figure 3G), suggesting that XBP-1-p-mediated induction of VEGFA is dose-dependent. To further confirm this idea, we compared expression levels of VEGFA in HepG2 cells transfected with siRNA directed against IRE1α, XBP-1, or control scramble siRNA under ER stress induced by thapsigargin. As we predicted, VEGFA mRNA induction was attenuated in the cells transfected with IRE1α siRNA and Xbp1 siRNA as compared to the cells transfected with control scramble siRNA (Figure 3H). Suppression of IRE1 and XBP1 signaling was confirmed by the downregulation of EDEM, which is a known downstream effector of XBP-1 [18].

The VEGFA promoter region contains one putative XBP-1-p binding site, the ACGT core [19], [20], 972 bp upstream of the mouse VEGFA start site, raising the possibility that XBP-1-p binds to VEGFA promoter. To test this idea, we derived a reporter construct by cloning 1 kb upstream sequences of the mouse VEGFA transcription start site upstream of the luciferase gene. Ectopic XBP-1-p expression increased activity of VEGFA promoter-luciferase (Figure 3I). In order to determine direct interaction of XBP1 with VEGFA, we did a chromatin immunoprecipitation (ChIP) analysis of the mouse VEGFA promoter. Mouse neuro2A cells either mock transfected or transfected with XBP-1-p, were treated with thapsigargin. ChIP analysis indicates that XBP-1-p was recruited to the mouse VEGFA promoter under ER stress conditions in vivo (Figure 3J). XBP-1-p overexpression improves binding efficiency which is further increased by ER stress thus supporting the idea of dose-dependent upregulation of VEGFA transcription under ER stress. Collectively, the results of Figure 3 show that VEGFA is a direct target of the IRE1α-XBP-1 pathway.

IRE1α Regulates VEGFA Expression in Labyrinthine Trophoblast Cells

Our group and others have previously reported that Ire1α−/− mice are embryonic lethal by embryonic day 12.5 [21], [22], [23]. It has been reported that the embryonic lethality of Ire1α−/− mice is due to the defect in the development of the labyrinthine trophoblast cells which are critical for integration and exchange between fetal and maternal blood vessels in the placenta [23]. It has previously been shown that loss of a single Vegfa allele in mice can result in embryonic lethality by embryonic day 11.5 due to a defect in the development of labyrinthine trophoblast cells [24]. We therefore considered the possibility that IRE1α has a role in the survival of labyrinthine trophoblast cells through the activation of VEGFA expression. As reported previously, we found that Ire1α−/− placentas failed to develop proper labyrinthine trophoblast on embryonic day 10.5 (Figure 4A). Because of the progressive loss of blood vessels in the labyrinthine layer, Ire1α−/−embryos were comparatively smaller in size than wild-type embryos and did not survive more than embryonic day 12.5 (Figure 4B and Table 1). To confirm the role of IRE1α signaling in mouse labyrinthine trophoblast cells, we also analyzed the mouse labyrinthine trophoblast cell line, SM10 [25]. These cells responded robustly to ER stress inducers, tunicamycin and thapsigargin as well as 2-deoxy glucose which causes glucose deprivation, as indicated by upregulation of spliced Xbp1 and Chop protein expression levels (Figure 4C, left panel). VEGFA mRNA was also induced significantly upon ER stress (Figure 4C, right panel). During embryonic development, HIF1α is activated in the growing placenta [8]. To confirm that HIF1α was not involved in ER stress-mediated VEGFA mRNA induction in SM10 cells, we knocked down HIF1α expression by siRNA and measured VEGFA mRNA expression. As expected, RNAi-mediated knockdown of HIF1α did not affect VEGFA mRNA induction by thapsigargin treatment in SM10 cells (Figure 4D).

Figure 4
Ire1α−/− mouse labyrinthine placenta defect is due to Ire1-dependent VEGFA expression.
Table 1
Mouse embryo survival data.

We next sought to verify that ER stress-mediated VEGFA mRNA induction required IRE1α in SM10 cells. We transduced SM10 cells with lentivirus expressing a kinase inactive K599A mutant form of IRE1α, which has been reported to act as a dominant-negative of wild-type IRE1α [16], [26], [27], or GFP as a control, then we induced physiological ER stress using glucose deprivation which normally occurs during placenta development [6], [7], [8]. In cells expressing kinase inactive K599A mutant form of IRE1, VEGFA mRNA levels were decreased as compared to control cells expressing GFP (Figure 4E). The suppression of IRE1α signaling by the kinase inactive IRE1α K599A mutant was confirmed by the attenuation of XBP-1 splicing (Figure 4E). Collectively, these results indicate that Ire1 has an essential function in VEGFA expression in the labyrinthine trophoblast cells which is independent of HIF1α activity.

ER Stress-Induced VEGFA Upregulation Is Also Dependent on PERK

As described above, IRE1α-XBP-1 signaling plays a role in the induction of VEGFA mRNA under ER stress conditions. However, the lack of IRE1α only partially attenuated VEGFA mRNA induction. Therefore, it is possible that other components of the UPR also play a role in VEGFA mRNA expression. To test this idea, we next sought to study the role of PERK signaling in VEGFA mRNA expression.

In Perk−/− MEFs, VEGFA mRNA induction by thapsigargin treatment was significantly attenuated as compared to wild-type MEFs (Figure 5A). To confirm that the decreased expression of VEGFA was due to lack of Perk expression, we analyzed the effect of Perk-rescue in Perk−/− cells. We transduced Perk−/− MEFs with lentivirus expressing PERK. To confirm that ectopically expressed PERK was functional, we treated the rescued cells along with wild-type and Perk−/− parental cells with thapsigargin and measured ATF4 and CHOP protein expression, two proteins regulated by PERK. As expected, ATF4 and CHOP protein expression levels were restored in the rescued cells (Figure 5B). VEGFA mRNA expression levels were also restored to wild-type levels under ER stress conditions in the rescued cells (Figure 5C). VEGF protein expression as well as secretion were also restored in the rescued cells (Figure 5D).

Figure 5
ER stress induced VEGFA upregulation is also dependent on Perk.

Previous studies have shown ATF4 translation is dependent on PERK and suggested that ATF4 plays a role in VEGF mRNA expression under oxidative stress [28], [29]. These considerations prompted us to investigate the role of ATF4 in VEGFA mRNA expression under ER stress conditions. We measured VEGFA mRNA expression in Atf4−/− MEFs and wild-type MEFs. Figure 5E shows that VEGFA mRNA levels were attenuated in Atf4−/− cells as compared to wild-type cells.

To further confirm the role of the PERK-ATF4 pathway in VEGFA mRNA induction, we transfected HepG2 cells with siRNAs directed against PERK and ATF4 and then measure VEGFA mRNA expression under ER stress conditions. RNAi-mediated knockdown of PERK and ATF4 in HepG2 cells resulted in a significant decrease of VEGFA mRNA expression (Figure 5F and G).

ATF4 has been previously shown to interact with first intron of the human VEGFA gene under oxidative stress conditions caused by arsenite treatment [28]. ATF4 interacts with an amino-acid response element (AARE) present in the intron. We therefore considered the possibility that ATF4 binds to the first intron of VEGFA gene under ER stress conditions.

To test this idea, a reporter plasmid carrying a 3.3 Kb fragment of intron 1 of the mouse VEGFA gene was cloned into pGL3 luciferase vector. Ectopic ATF4 expression, but not XBP-1, increased the activity of the reporter (Figure 5H). ChIP analysis was performed on neuro2A cells in order to confirm the interaction. The ChIP PCR product comprised of 109 bp starting from +1581 of the 2891 bp mouse VEGFA intron1.The ChIP experiments revealed that following addition of thapsigargin, ATF4 was recruited to the VEGFA intron 1 (Figure 5I). Collectively, these results indicate that the PERK-ATF4 pathway directly regulates VEGFA mRNA expression through intron 1 of VEGFA gene under ER stress condtions.

ATF6α Also Plays a Role in VEGFA mRNA Upregulation under ER Stress

ATF6α, an ER transmembrane protein, is another upstream component of the UPR. Under ER stress conditions ATF6α translocates from ER to the Golgi where its cytoplasmic domain is cleaved from the membrane to produce a potent transcription factor regulating UPR target genes [30]. XBP-1 is one of the targets of cleaved-ATF6α [31]. Hence, we tested the possibility if ATF6α was involved in VEGFA mRNA expression under ER stress conditions. As predicted, RNAi-mediated knockdown of ATF6α in HepG2 cells resulted in a significant decrease of VEGFA mRNA expression under ER stress conditions (Figure 6A). To further establish a relationship between ATF6α and VEGFA mRNA induction, we tested if ATF6α could increase the activity of gene regulatory regions of VEGFA gene. Ectopic expression of cleaved active ATF6α increased the activity of VEGFA-promoter reporter (Figure 6B), but not VEGFA-intron reporter (Figure 6C). Collectively, these results strongly suggest that ATF6α also plays role in VEGFA mRNA induction by binding its promoter under ER stress conditions.

Figure 6
ATF6 has an active role in ER stress-induced VEGFA upregulation.


Our results indicate that the UPR is activated not only by ER stress but also deprivation of nutrients and oxygen, and robustly regulates VEGFA mRNA expression. The regulation of VEGFA by ER stress is mediated by UPR master regulators, IRE1α, PERK and ATF6α via their respective transcription factors, XBP-1, ATF4 and cleaved-ATF6 respectively (Figure 7). Our results show that VEGFA induction by ER stress is independent of the hypoxia inducible factor 1 (HIF-1) pathway, a major signaling pathway for VEGFA induction by hypoxia [13] or there is a cross-talk between the XBP-1, ATF4, ATF6α, and HIF-1 pathways. The robust induction of VEGFA by IRE1α signaling is also important for the development and survival of labyrinthine trophoblast cells in the placenta.

Figure 7
VEGFA expression is regulated by ER stress.

VEGFA is the major vascular endothelial growth factor and plays prominent roles in angiogenesis [32]. Angiogenesis is crucial to many physiological and pathological processes including development of labyrinthine trophoblast cells in the placenta [24], [33], [34]. Mammalian placenta is a vital secretory organ characterized by secretion of large amounts of diverse proteins like placental lactogens, proliferins and other growth factors required for the growing embryo. In mice, the placenta is formed by fusion of the embryo-derived allantois (i.e., umbilical cord) and the extra-embryonic chorion which derives from the polar trophectoderm overlying the embryo. Chorioallantoic attachment at embryonic day 8.5 causes chorionic trophoblast to differentiate into various layers of labyrinthine trophoblast cells. These labyrinthine trophoblast cells undergo extensive villus branching to form the labyrinth by embryonic day 10.5 [34]. The formation of this layer is critical for integration and exchange between fetal and maternal blood vessels [6], [33]. It has been reported that hypoxia and nutrient deprivation, which have been shown to activate both IRE1α and PERK in this study, are involved in various stages of placental development, one of them being trophoblast differentiation [6], [7], [8]. Our results suggest that the generation of a fully functional labyrinthine trophoblast requires a coordinated action of downstream effectors regulated by IRE1α including VEGFA which is independent of HIF1α signaling.

Angiogenesis is crucial for sustaining tumors. IRE1α signaling is known to be essential for angiogenesis and growth of tumor cells through VEGFA induction [3], [5]. PERK signaling also has been shown to be important for survival of tumor cells [35]. Our data show that the IRE1α-XBP-1, PERK-ATF4, and ATF6α pathways can independently regulate VEGFA mRNA expression under ER stress conditions via different regulatory regions of the VEGFA gene. Our results show that both VEGFA promoter as well as the intron is engaged simultaneously by UPR effectors under ER stress conditions. This tells us that coordinated activation of all three regulators is essential for proper upregulation of VEGFA mRNA expression. Inactivation or knockdown of any of these three master regulators impairs VEGFA upregulation under ER stress.

Many downstream target genes of the UPR are co-regulated by IRE1α, PERK, and ATF6α, ensuring the redundancy and robustness of this adaptive response. However, this biological design that mediates robustness also has drawbacks. In cancer cells, VEGFA induction mediated by the UPR is used to maintain abnormal ER homeostasis and help these cells to survive and proliferate under chronic ER stress conditions caused by nutrient deprivation and hypoxia. Thus, inhibiting IRE1α, PERK, and ATF6α is a promising novel therapeutic modality for cancer treatment.

Materials and Methods

Cell Culture

Hepatocellular cell line, HepG2, and human prostate cancer cell line, PC3, were obtained from ATCC. HepG2 was maintained in MEM with supplements according to ATCC cell culture instructions. PC3 was maintained in DMEM with 10% FBS. Rat insulinoma cells, INS-1 832/13, were a gift from Dr. Christopher Newgard (Duke University Medical Center) and cultured in RPMI 1640 supplemented with 10% FBS. Ire1α−/− and Perk−/− mouse embryonic fibroblasts were gifts from Dr. David Ron (New York University School of Medicine) and maintained in DMEM 10% FBS. Mouse labyrinthine trophoblast SM10 cells were a gift from Dr. Joan Hunt (University of Kansas) and maintained in RPMI 1640 supplemented with 2 mM glutamine, 1% sodium pyruvate, 5×10−5 M 2-Mercaptoethanol and 10% FBS. Human embryonic kidney 293T cells and Mouse neuro2a cells were obtained from ATCC and maintained in DMEM with 10% FBS.


Mouse Atf4, mouse Xbp1-processed, mouse Perk, human Ire1α and human Ire1αKA (K599A) dominant-negative kinase mutant plasmids were provided by Dr. David Ron (New York University School of Medicine). Mouse ATF5 plasmid was a gift from Dr. Michael Green (University of Massachusetts Medical School). Cleaved processed ATF6([open triangle]373) plasmid was provided by Dr. R. Prywes (Columbia University).

Lentivirus System

Lentivirus expressing human IRE1α, human IRE1αKA and mouse Perk and GFP were generated by subcloning these fragments into lentiviral expression plasmid, pLenti-CMV/TO (Dr. Eric Campeau at the University of Massachusetts Medical School). Lentivirus was produced in HEK293T cells by transfection using Lipofectamine2000 (Invitrogen Carlsbad, CA). Lentiviral supernatant was collected 48 hours after transfection, and stored at −80°C. Details of this lentivirus system were described previously [36]. Ire1α−/− and Perk−/− cells were infected with human IRE1α and mouse Perk lentivirus respectively and selected with puromycin 2 µg/ml to generate stable cell lines. SM10 cells were infected with human IRE1αKA and control GFP lentivirus and selected with Puromycin 1 µg/ml to generate stable cell lines.

siRNA and Plasmid Transfection

Small interfering RNA (siRNA) was transfected using the Nucleofector Device (Amaxa Biosystems, Gaithersburg, MD) into HepG2 cells according to manufacturer recommendations. Human HIF1-α smart pool siRNA was obtained from Dharmacon, (Lafayette, CO). SiRNAs directed against human PERK, human IRE1α, human ATF4 and human XBP1 were synthesized by IDT (Coralville, IA): for human PERK: CCAGAGAAGTGGCAAGAAA; for human IRE1: AGACAGAGGCCAAGAGCAA; for human ATF4: GCAAAGAGCTGGAAAAGAA; for human XBP1: GGTATTGACTCTTCAGATT. Cells were incubated in media for overnight after siRNA transfection, and then put under ER stress conditions. Mouse XBP1-processed plasmid was transfected using the Nucleofector device (Amaxa Biosystems, Gaitherburg, MD) into mouse embryonic fibroblasts according to manufacturer recommendations.

Western Blotting

Cells were lysed in M-PER (Pierce, Rockford IL) for whole cell protein extraction, or NE-PER (Pierce, Rockford IL) for nuclear and cytoplasmic protein extraction, after adding protease inhibitor (Sigma, Saint Louis, MO) according to supplier protocol. Lysates were run on a 4%–20% linear gradient SDS-PAGE (BioRad, Hercules, CA) gel. Anti-Atf4 (anti-CREB-2 H-290), Anti-Xbp1, anti- CHOP/GADD153 and anti-Actin antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-Ire1α, anti-Perk antibodies was obtained from Cell Signaling (Danvers, MA). Anti-Hif1α, Anti-phospho Ire1 antibodies was obtained from Novus Biologicals (Littleton, CO).

Quantitative Polymerase Chain Reaction

Total RNA was isolated from the cells by using the RNeasy Mini Kit (Qiagen, Valencia, CA). 1 µg of total RNA from cells was reverse transcribed with Oligo-dT primer (Promega, Madison, WI). For the thermal cycle reaction, the iQ5 system (BioRad, Hercules, CA) was used at 95°C for 10 min, then 40 cycles at 95°C for 10 sec, and at 55°C for 30 sec. The relative amount for each transcript was calculated by a standard curve of cycle thresholds for serial dilutions of cDNA sample and normalized to the amount of the house-keeping beta-actin levels. The polymerase chain reaction (PCR) was performed in triplicate for each sample; all experiments were repeated three times. Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) was used for the quantitative PCR. PCR primer sequences are listed in Table S1.

mRNA Stability Assay

Cellular mRNA transcription was attenuated by treating cells with 5 µg/ml Actinomycin D (Sigma A-4262) for 1 hr. followed by treatment with thapsigargin (0.2 µM) for different times. Total RNA was collected and quantitative PCR method described above was employed to measure levels of VEGFA gene transcripts. Time point zero for each condition was standardized to 1 and the subsequent rate of degradation of mRNA was measured.

Luciferase Assay

Mouse Vegfa 1 Kb (−1039 to 0) promoter and 3.3 Kb Intron (460 bp Exon 1+2891 bp Intron 1) was cloned from Mouse BAC clone RP23 (Invitrogen, Carlsbad, CA) into Xho1/HindIII site of pGL3 luciferase vector (Promega, Madison, WI). 293T cells were transfected with both reporters as well as mock pGL3 vector along with Atf4, processed-Xbp1, processed-Atf6 (Δ373) and Atf5 by Lipofectamine™ 2000 (Invitrogen, Carlsbad, CA). Twenty-four hrs post-transfection, lysates were prepared using a Luciferase Assay System kit (Promega, Madison, WI) according to manufacturer's protocol. The light produced from the samples was read by a standard plate reading luminometer. Each sample was read in triplicate and normalized against the signal produced from mock wells. β-galactosidase activity was measured by β-Gal Reporter Gene Assay, chemiluminescent (Roche Diagnostics, Mannheim, Germany). The assay was performed independently three times.

Chromatin Immunoprecipitation (ChIP)

Mouse neuro2a cells were transfected with pFlag-CMV-2 and processed-Xbp1 expression plasmids by Lipofectamine™ 2000 (Invitrogen, Carlsbad, CA). After 36 hrs, cells were treated with or without thapsigargin for further 6 hrs and fixed in 1% formaldehyde. Untransfected Neuro2a cells were also treated with or without thapsigargin for 6 hrs and fixed in 1% formaldehyde ChIPs were performed using SimpleChIP™ Enzymatic Chromatin IP Kit (Agarose Beads) (Cell Signaling, Danvers, MA) as per manufacturer's recommendation. Antibodies against Xbp1 and ATF4 from Santa Cruz Biotechnology (Santa Cruz, CA) as well as a negative control, rabbit IgG, were used for ChIP assay. Purified DNA from cross-linked cells was dissolved in 25 µl TE; 2 µl was used for PCR. Inputs consisted of 10% chromatin before immunoprecipitation. Quantitative PCRs were performed as described in Quantitative polymerase chain reaction section using following primer sets: for mouse Vegfa promoter, ATTTCCTGGGAAAGGGAATTG and TCCACGGCCTCAAAATTATC; for mouse Vegfa intron 1, GCCACAGTGTGACCTTCAGA and CGTGGAGAAAGGGAACAGAA.


WT, Ire1α−/−, Perk−/−, Ire1 rescued and Perk rescued mouse embryonic fibroblasts were treated with media without glucose as indicated. Both supernatant medium as well as whole cell lysates were collected. Mouse VEGF secreted protein from supernatant and lysates were measured via ELISA analysis using Bio-Plex 200 System (BioRad, Hercules, CA) at the UMass Mouse Phenotyping Center at University of Massahusetts Medical School, Worcester, MA.

Ire1α+/− Animals

Ire1α+/− mice on 129 background are maintained at the animal medicine core at UMass Medical School (Worcester, MA).

Supporting Information

Figure S1

Ire1α does not affect VEGF mRNA stability. WT and Ire1α−/− MEFs were treated with or without actinomycin D (5 µg/ml) for 1 hr. Cells were then treated with ER stress inducer, thapsigargin (Tg, 1 µM) for 0, 1.5 or 3 hrs. Total mRNA was collected and expression levels of VEGFA were measured by quantitative PCR (n = 3, values are mean ± SD).

(2.72 MB TIF)

Table S1

Quantitative PCR Primer Sequences. The following table indicates sets of primers used for quantitative PCR.

(0.04 MB DOC)


We thank S. Ishigaki for helpful discussions and C. Oslowski for critical reading of the manuscript.


Competing Interests: The authors have declared that no competing interests exist.

Funding: Research in the laboratory of F. Urano is supported by a National Institutes of Health (NIH) R01DK067493 grant, a grant from the Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School (DK032520), and a Juvenile Diabetes Research Foundation Regular Research Grant (1-2008-593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8:519–529. [PubMed]
2. Rutkowski DT, Kaufman RJ. That which does not kill me makes me stronger: adapting to chronic ER stress. Trends Biochem Sci. 2007;32:469–476. [PubMed]
3. Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee AH, et al. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 2004;64:5943–5947. [PubMed]
4. Koumenis C, Bi M, Ye J, Feldman D, Koong AC. Hypoxia and the unfolded protein response. Methods Enzymol. 2007;435:275–293. [PubMed]
5. Drogat B, Auguste P, Nguyen DT, Bouchecareilh M, Pineau R, et al. IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo. Cancer Res. 2007;67:6700–6707. [PubMed]
6. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet. 2001;2:538–548. [PubMed]
7. Adelman DM, Gertsenstein M, Nagy A, Simon MC, Maltepe E. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev. 2000;14:3191–3203. [PubMed]
8. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science. 1997;277:1669–1672. [PubMed]
9. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843–845. [PubMed]
10. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A. 1995;92:768–772. [PubMed]
11. Stein I, Neeman M, Shweiki D, Itin A, Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol. 1995;15:5363–5368. [PMC free article] [PubMed]
12. Abcouwer SF, Marjon PL, Loper RK, Vander Jagt DL. Response of VEGF expression to amino acid deprivation and inducers of endoplasmic reticulum stress. Invest Ophthalmol Vis Sci. 2002;43:2791–2798. [PubMed]
13. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16:4604–4613. [PMC free article] [PubMed]
14. Hollien J, Lin JH, Li H, Stevens N, Walter P, et al. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J Cell Biol. 2009;186:323–331. [PMC free article] [PubMed]
15. Hollien J, Weissman JS. Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science. 2006;313:104–107. [PubMed]
16. Lipson KL, Ghosh R, Urano F. The Role of IRE1alpha in the Degradation of Insulin mRNA in Pancreatic beta-Cells. PLoS ONE. 2008;3:e1648. [PMC free article] [PubMed]
17. Han D, Lerner AG, Vande Walle L, Upton JP, Xu W, et al. IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell. 2009;138:562–575. [PMC free article] [PubMed]
18. Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol. 2003;23:7448–7459. [PMC free article] [PubMed]
19. Kanemoto S, Kondo S, Ogata M, Murakami T, Urano F, et al. XBP1 activates the transcription of its target genes via an ACGT core sequence under ER stress. Biochem Biophys Res Commun. 2005;331:1146–1153. [PubMed]
20. Clauss IM, Chu M, Zhao JL, Glimcher LH. The basic domain/leucine zipper protein hXBP-1 preferentially binds to and transactivates CRE-like sequences containing an ACGT core. Nucleic Acids Res. 1996;24:1855–1864. [PMC free article] [PubMed]
21. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science. 2000;287:664–666. [PubMed]
22. Zhang K, Wong HN, Song B, Miller CN, Scheuner D, et al. The unfolded protein response sensor IRE1alpha is required at 2 distinct steps in B cell lymphopoiesis. J Clin Invest. 2005;115:268–281. [PMC free article] [PubMed]
23. Iwawaki T, Akai R, Yamanaka S, Kohno K. Function of IRE1 alpha in the placenta is essential for placental development and embryonic viability. Proc Natl Acad Sci U S A. 2009;106:16657–16662. [PubMed]
24. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439–442. [PubMed]
25. Selesniemi K, Reedy M, Gultice A, Guilbert LJ, Brown TL. Transforming growth factor-beta induces differentiation of the labyrinthine trophoblast stem cell line SM10. Stem Cells Dev. 2005;14:697–711. [PubMed]
26. Tirasophon W, Lee K, Callaghan B, Welihinda A, Kaufman RJ. The endoribonuclease activity of mammalian IRE1 autoregulates its mRNA and is required for the unfolded protein response. Genes Dev. 2000;14:2725–2736. [PubMed]
27. Lipson KL, Fonseca SG, Ishigaki S, Nguyen LX, Foss E, et al. Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1. Cell Metab. 2006;4:245–254. [PubMed]
28. Roybal CN, Hunsaker LA, Barbash O, Vander Jagt DL, Abcouwer SF. The oxidative stressor arsenite activates vascular endothelial growth factor mRNA transcription by an ATF4-dependent mechanism. J Biol Chem. 2005;280:20331–20339. [PubMed]
29. Oskolkova OV, Afonyushkin T, Leitner A, von Schlieffen E, Gargalovic PS, et al. ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response. Blood. 2008;112:330–339. [PubMed]
30. Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem. 2005;74:739–789. [PubMed]
31. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 2001;107:881–891. [PubMed]
32. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669–676. [PubMed]
33. Rinkenberger J, Werb Z. The labyrinthine placenta. Nat Genet. 2000;25:248–250. [PubMed]
34. Rossant J, Howard L. Signaling pathways in vascular development. Annu Rev Cell Dev Biol. 2002;18:541–573. [PubMed]
35. Blais JD, Addison CL, Edge R, Falls T, Zhao H, et al. Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol Cell Biol. 2006;26:9517–9532. [PMC free article] [PubMed]
36. Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, et al. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One. 2009;4:e6529. [PMC free article] [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science